home / stock / clxpf / clxpf news


CLXPF News and Press, Canadian Lynx Pete Ltd From 04/16/21

Stock Information

Company Name: Canadian Lynx Pete Ltd
Stock Symbol: CLXPF
Market: OTC
Website: cybin.com

Menu

CLXPF CLXPF Quote CLXPF Short CLXPF News CLXPF Articles CLXPF Message Board
Get CLXPF Alerts

News, Short Squeeze, Breakout and More Instantly...

CLXPF - Psychedellux April 16, 2021

This is Psychedellux – the week’s top business news in the psychedelics industry. Cybin said it was Starting the IND-enabling trials for CYB003 and CYB004 which is a step forward for Cybin to study these molecules. Our team hopes to produce a robust submission to the FDA t...

CLXPF - California Senate Committee Approves Psychedelic Decriminalization Measure

Earlier this month, a measure to decriminalize psychedelics in the state of California was advanced to the Senate Public Safety Committee. The committee also passed a separate bill that would enable communities in the state to temporarily open safe consumption sites for illegal drugs. Th...

CLXPF - PsychedelicNewsBreaks - Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces Advancement of IND-Enabling Studies of Psychedelic Molecules for IND Applications

Cybin (NEO: CYBN) (OTCQB: CLXPF) , a biotechnology company focused on progressing psychedelic therapeutics, has plans to advance the preclinical work for two of its deuterated tryptamine development candidates: its orally dissolving tablet (“ODT”) formulation of CYB003 and its...

CLXPF - Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004 for Investigational New Drug Applications

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced plans to advance the pre-clinical work for its orally dissolving tablet (“ODT...

CLXPF - New UCSF Research Program to Focus on Psychedelics Research and Treatments' Advancement

The formation of the University of California Neuroscape Psychedelics Division will help advance psychedelic research on brain health through $6.4 million in private financing. The new division at UCSF will employ a translational research approach that will integrate psychedelic treatm...

CLXPF - Why Mainstream Mental-Health Care is Embracing Psilocybin - Alternative Active Substances

Palm Beach, FL – March 31, 2021 – Psychedelic healing may sound like a fad from the Woodstock era, but it’s a field of study that’s gaining traction in the medical community as an effective treatment option for a growing number of mental health conditions. While ...

CLXPF - Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe

Cybin Inc. ( NEO:CYBN ) ( OTCQB:CLXPF ) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced key senior management changes to lead the buildout of its development and ...

CLXPF - Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 26, 2021 – USA News Group –  Expanding way beyond just hunting for the perfect truffle, rising interest in the “ megascience ” of mycology is creating...

CLXPF - Cybin Inc. (NEO: CYBN) at Forefront of Psychedelic Revolution

NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “Science Drives Surging Interest in Psychedelic Therapeutics.” To hear the AudioPressRelease, please visit: The Netw...

CLXPF - Cybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic Medicine Surges

NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a mu...

Previous 10 Next 10